AnalystsMichael FreemanMichael Freeman's Stock Forecasts
AnalystsMichael Freeman
Sectors:
Analyst Ranking
Bottom 20%
#3968 out of 4929 analysts
Average Return
-10.73%
Win Rate
20%1 out of 5
Risk vs Reward
Poor
Good
Michael Freeman's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Disc Medicine IncIRON | +7.65% | $50.86 | $54.75 | 2025-06-11 - 2025-07-03 | Strong Buy |
Michael Freeman Analyst Color
Get additional color on Michael Freeman's coverage of popular stocks
Michael Freeman's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Wave Life Sciences LtdWVE | 1 | Buy | $14.00 | +101.44% | Assumes | 24 days ago |
Tectonic Therapeutic IncTECX | 1 | Buy | $76.00 | +256.14% | Reinstates | 24 days ago |
Dyne Therapeutics IncDYN | 1 | Buy | $37.00 | +322.37% | Assumes | 24 days ago |
Disc Medicine IncIRON | 1 | Strong Buy | $89.00 | +62.56% | Reinstates | 24 days ago |
Avidity Biosciences IncRNA | 1 | Strong Buy | $65.00 | +122.83% | Initiates Coverage On | 24 days ago |
Bausch Health Companies IncBHC | 1 | Hold | $8.00 | +13.31% | Initiates Coverage On | a year ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.